EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 2 (2016) SICOT-J, 2 (2016) 24 References
Open Access
Issue
SICOT-J
Volume 2, 2016
Article Number 24
Number of page(s) 7
Section Lower Limb
DOI https://doi.org/10.1051/sicotj/2016016
Published online 16 May 2016
  1. Ahlborg HG, Johnell O, Nilsson BE, Jeppsson S, Rannevik G, Karlsson MK (2001) Bone loss in relation to menopause: a prospective study during 16 years. Bone 28(3), 327–331. [CrossRef] [PubMed] [Google Scholar]
  2. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC (1976) Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 307, 1038–1040. [CrossRef] [Google Scholar]
  3. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85(2), 304–313. [CrossRef] [PubMed] [Google Scholar]
  4. Persson I, Adami HO, Bergkvist L et al. (1989) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: esults of a prospective study. British Med J 298, 147–151. [CrossRef] [Google Scholar]
  5. Eser O, Aslan A, Coşar M, Kalkan E, Albayrak R (2010) Kyphoplasty method for the treatment of traumatic osteoporotic vertebral compression fractures: case report. Ulus Travma Acil Cerrahi Derg 16(1), 95–97. [PubMed] [Google Scholar]
  6. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H (2000) Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11, 721–724. [CrossRef] [PubMed] [Google Scholar]
  7. Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC (1999) Health potential of soy isoflavones for menopausal women. Public Health Nutr 2, 489–504. [PubMed] [Google Scholar]
  8. Tsuang YH, Chen LT, Chiang CJ et al. (2008) Isoflavones prevent bone loss following ovariectomy in young adult rats. J Orthop Surg Res 3, 12. [CrossRef] [PubMed] [Google Scholar]
  9. Albertazzi P (2002) Purified phytoESTs in postmenopausal bone health: is there a role for GEN? Climacteric 5, 190–196. [CrossRef] [PubMed] [Google Scholar]
  10. Pike MC, Peters RK, Cozen W et al. (1997) Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst 89(15), 1110–1116. [CrossRef] [PubMed] [Google Scholar]
  11. Weiderpass E, Adami HO, Baron JA et al. (1991) Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 91(1), 1131–1137. [CrossRef] [Google Scholar]
  12. Pike MC, Ross RK (2000) Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids 65(10–11), 659–664. [CrossRef] [PubMed] [Google Scholar]
  13. Morabito N, Crisafulli A, Vergara C et al. (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double blind placebo-controlled study. J Bone Miner Res 17, 1904–1912. [CrossRef] [PubMed] [Google Scholar]
  14. Marini H, Minutoli L, Polito F et al. (2007) Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 146, 839–847. [CrossRef] [PubMed] [Google Scholar]
  15. Harrison E, Adjei A, Ameho C, Yamamoto S, Kono S (1997) The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis. J Nutr Sci Vitaminol 44, 257–268. [CrossRef] [Google Scholar]
  16. Arjmandi BH, Alekel L, Hollis BW et al. (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126, 161–167. [CrossRef] [PubMed] [Google Scholar]
  17. Kuiper GG, Lemmen JG, Carlsson B et al. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor B. Endocrinology 139, 4252–4263. [PubMed] [Google Scholar]
  18. Sehmisch S, Uffenorde J, Maehlmeyer S, Tezval M, Jarry H, Stuermer KM, Stuermer EK (2010) Evaluation of bone quality and quantity in osteoporotic mice – the effects of genistein and equol. Phytomedicine 17(6), 424–430. [CrossRef] [PubMed] [Google Scholar]
  19. Bitto A, Burnett BP, Polito F et al. (2008) Effects of GEN aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Br J Pharmacol 155, 896–905. [CrossRef] [PubMed] [Google Scholar]
  20. Huang AJ, Ettinger B, Vittinghoff E, Ensrud KE, Johnson KC, Cummings SR (2007) Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. J Bone Miner Res 22(11), 1791–1797. [CrossRef] [PubMed] [Google Scholar]
  21. Ettinger B (2007) Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Maturitas 57(1), 81–84. [CrossRef] [PubMed] [Google Scholar]
  22. Miao Q, Li JG, Miao S et al. (2012) The bone-protective effect of genistein in the animal model of bilateral ovariectomy: roles of phytoestrogens and PTH/PTHR1 against post-menopausal osteoporosis. Int J Mol Sci 13(1), 56–70. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.